Form 4: Zivo Bioscience Director and 10% Owner Increases Stake with Significant Stock and Warrant Purchase

Laith L. Yaldoo, a Director and 10% Owner of Zivo Bioscience, Inc., has increased his beneficial ownership through the purchase of common stock and warrants totaling over $50,000.

Summary

• Laith L. Yaldoo, a Director and 10% Owner of Zivo Bioscience, Inc. (ZIVO), purchased additional securities.
• On June 13, 2025, Mr. Yaldoo acquired 3,488 shares of common stock at a price of $14.33 per share, totaling approximately $50,000.64.
• Following this transaction, Mr. Yaldoo indirectly beneficially owns 558,114 shares of common stock through HEP Investments LLC.
• Additionally, on the same date, Mr. Yaldoo purchased 348 warrants for common stock, each with an exercise price of $14.33.
• These warrants are exercisable immediately (June 13, 2025) and expire on June 13, 2030.
• Mr. Yaldoo indirectly beneficially owns 348 warrants through HEP Investments LLC.

Sentiment

Score: 8

Explanation: The significant purchase of both common stock and warrants by a director and 10% owner indicates strong confidence in the company's future, which is a highly positive signal for investors.

Positives

• A Director and 10% Owner, Laith L. Yaldoo, increased his stake in the company, signaling confidence in Zivo Bioscience's future prospects.
• The purchase of 3,488 shares of common stock and 348 warrants at $14.33 per share/warrant demonstrates a direct financial commitment from a key insider.
• Insider buying can often be interpreted by the market as a positive indicator of the company's intrinsic value or anticipated positive developments.

Future Outlook

NA

Industry Context

Insider purchases, especially by significant stakeholders like a Director and 10% Owner, often suggest a positive internal view of the company's prospects, potentially indicating an undervaluation or anticipated positive developments within the biotechnology or bioscience industry.

Related Party Transactions

• The reported transactions (purchase of common stock and warrants) were conducted indirectly through HEP Investments LLC, which is beneficially owned by the reporting person, Laith L. Yaldoo.

Stakeholder Impact

• Shareholders: The insider purchase may instill greater confidence among existing and potential shareholders, potentially leading to increased demand for the stock.
• Employees: While not directly impacted, a positive signal from leadership can indirectly boost morale and confidence in the company's stability and future.

Key Dates

Recommendation

Keywords

Zivo Bioscience, ZIVO, Insider Trading, Form 4, Common Stock, Warrants, Director, 10% Owner, Stock Purchase, Beneficial Ownership, Laith L. Yaldoo, HEP Investments LLC